Phase II Pilot Efficacy Trial of Sunitinib for Refractory Malignant Ascites.
Phase of Trial: Phase II
Latest Information Update: 07 May 2017
At a glance
- Drugs Sunitinib (Primary)
- Indications Malignant ascites
- Focus Therapeutic Use
- 28 Apr 2011 Planned End Date changed from 1 Dec 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 28 Apr 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 01 Dec 2008 New trial record.